✦ LIBER ✦

Investigation of the Cause of Death in a Gene-Therapy Trial

✍ Scribed by Frank, Karen M.; Hogarth, D. Kyle; Miller, Jonathan L.; Mandal, Saptarshi; Mease, Philip J.; Samulski, R. Jude; Weisgerber, Glen A.; Hart, John

Book ID: 118044558
Publisher: Massachusetts Medical Society
Year: 2009
Tongue: English
Weight: 622 KB
Volume: 361
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmoa0801066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nosological coding of cause of death in

Nosological coding of cause of death in a clinical trial

✍ Curb, J.D.; Babcock, C.; Pressel, S.; Tung, B.; Hawkins, C.M. 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 164 KB

An investigation of the cause of death f

An investigation of the cause of death from cancer

✍ Lorne Houten; Andrew A. Reilley 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

Who should code cause of death in a clin

Who should code cause of death in a clinical trial?

✍ Remington, Richard D. 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 297 KB

The trials of gene therapy

📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 42 KB

Assessing disease-specific causes of dea

Assessing disease-specific causes of death in a trial of all-cause mortality

✍ Jan A. Markowitz; Marie Diener-West; Claudia S. Moy; COMS Mortality Coding Commi 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Assessment of causes of death in a prost

Assessment of causes of death in a prostate cancer screening trial

✍ Tuukka Mäkinen; Pekka Karhunen; Jussi Aro; Jorma Lahtela; Liisa Määttänen; Anssi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 83 KB 👁 1 views

## Abstract Accurate assessment of the causes of death is crucial for a conclusive evaluation of the ongoing prostate cancer screening trials. Here, we report the validity of the official causes of death as compared with an independent expert review in the Finnish prostate cancer screening trial. B